Plasma membrane injury depends on bilayer lipid composition in alzheimer's disease

Journal of Alzheimer's Disease

Volumn 41, Issue 1, 2014, Pages 289-300

  Evangelisti, Elisa ^a   Zampagni, Mariagioia ^a   Cascella, Roberta ^a   Becatti, Matteo ^a   Fiorillo, Claudia ^a   Caselli, Anna ^a   Bagnoli, Silvia ^b   Nacmias, Benedetta ^b   Cecchi, Cristina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease fibroblasts; calcium dysregulation; lipid rafts; membrane cholesterol; membrane permeabilization; prion

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; CHOLESTEROL; MEMBRANE LIPID; OLIGOMER; PRION PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); APP PROTEIN, NEISSERIA MENINGITIDIS; CALCIUM; OUTER MEMBRANE PROTEIN; PEPTIDE FRAGMENT; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; LIPID BILAYER; LIPID COMPOSITION; LIPID RAFT; MEMBRANE DAMAGE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; RAT; ANIMAL; BRAIN CORTEX; CELL CULTURE; CELL MEMBRANE; CYTOSOL; GENETICS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CALCIUM; CELL LINE, TUMOR; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CEREBRAL CORTEX; CHOLESTEROL; CYTOSOL; FIBROBLASTS; MEMBRANE MICRODOMAINS; NEURONS; PEPTIDE FRAGMENTS; PRESENILIN-1; PRPC PROTEINS; RATS, SPRAGUE-DAWLEY;

EID: 84902283167     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131406     Document Type: Article

References (49)

1. Goedert M, Spillantini MG (2006) A century of AD. Science 314, 777-781.
2. Cruts M, Van Broeckoven C (1998) Molecular genetics of Alzheimer's disease. Ann Med 30, 560-565.
3. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.
4. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
5. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from AB are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95, 6448-6453.
6. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid fj protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
7. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284, 4230-4237.
8. Murray IV, Liu L, Komatsu H, Uryu K, Xiao G, Lawson JA, Axelsen PH (2007) Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J Biol Chem 282, 9335-9345.
9. Schengrund CL (2010) Lipid rafts: Keys to neurodegenera-tion. Brain Res Bull 82, 7-17.
10. Evangelisti E, Wright D, Zampagni M, Cascella R, Fiorillo C, Bagnoli S, Relini A, Nichino D, Scartabelli T, Nacmias B, Sorbi S, Cecchi C (2013) Lipidrafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer's disease. Curr Alzheimer Res 10, 143-153.
11. Poirier J (2003) Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med 9, 94-101.
12. Fonseca AC, Resende R, Oliveira CR, Pereira CM (2010) Cholesterol and statins in Alzheimer's disease: Current controversies. Exp Neurol 223, 282-293.
13. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95, 6460-6464.
14. Ehehalt R, Keller P, Haass C, Thiele C, Simons K (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160, 113-123.
15. Arispe N, Doh M (2002) Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J16, 1526-1536.
16. Yip CM, Elton EA, Darabie AA, Morrison MR, McLaurin J (2001) Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol 311, 723-734.
17. Cecchi C, Nichino D, Zampagni M, Bernacchioni C, Evangelisti E, Pensalfini A, Liguri G, Gliozzi A, Stefani M, Relini A (2009) A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells. Biochim Biophys Acta 1788, 2204-2216.
18. Greeve I, Hermans-Borgmeyer I, Brellinger C, Kasper D, Gomez-Isla T, Behl C, Levkau B, Nitsch RM (2000) The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegener-ation and oxidative stress. J Neurosci 20, 7345-7352.
19. Crameri A, Biondi E, Kuehnle K, Lütjohann D, Thelen KM, Perga S, Dotti CG, Nitsch RM, Ledesma MD, Mohajeri MH (2006) The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo. EMBO J 25, 432-443.
20. Cecchi C, Rosati F, Pensalfini A, Formigli L, Nosi D, Liguri G, Dichiara F, Morello M, Danza G, Pieraccini G, Peri A, Serio M, Stefani M (2008) Seladin-1/DHCR24 protects neuroblastoma cells against Abeta toxicity by increasing membrane cholesterol content. J Cell Mol Med 12, 1990-2002.
21. Ricciarelli R, Canepa E, Marengo B, Marinari UM, Poli G, Pronzato MA, Domenicotti C (2012) Cholesterol and Alzheimer's disease: A still poorly understood correlation. IUBMB Life 64, 931-935.
22. Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL (2001) Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem 79, 595-605.
23. Pensalfini A, Zampagni M, Liguri G, Becatti M, Evange-listi E, Fiorillo C, Bagnoli S, Cellini E, Nacmias B, Sorbi S, Cecchi C (2011) Membrane cholesterol enrichment prevents Afj-induced oxidative stress in Alzheimer's fibroblasts. Neurobiol Aging 32, 210-222.
24. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC.
25. The Dementia Study Group of the Italian Neurological Society (2000) Guidelines for the diagnosis of dementia and Alzheimer's disease. Ital J Neurol Sci 21, 87-194.
26. Lai CH, Chang YC, Du SY, Wang HJ, Kuo CH, Fang SH, Fu HW, Lin HH, Chiang AS, Wang WC (2008) Cholesterol depletion reduces Helicobacter pylori CagA translocation and CagA-induced responses in AGS cells. Infect Immun 76, 3293-3303.
27. Cecchi C, Evangelisti E, Cascella R, Zampagni M, Benvenuti S, Luciani P, Deledda C, Cellai I, Wright D, Saccardi R, Peri A, Stefani M (2011) Neuronal differentiation of human mesenchymal stromal cells increases their resistance to Afj42 aggregate toxicity. J Alzheimers Dis 27, 651-664.
28. Rasband WS (1997-2008) ImageJ, US, National Institutes of Health, Bethesda, Maryland, http://rsb.info.nih.gov/ij/.
29. Zampagni M, Cascella R, Casamenti F, Grossi C, Evangelisti E, Wright D, Becatti M, Liguri G, Mannini B, Campioni S, Chiti F, Cecchi C (2011) A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med 15, 2106-2116.
30. Rushworth JV, Hooper NM (2010) Lipid rafts: Linking Alzheimer's amyloid-fj production, aggregation, and toxicity at neuronal membranes. Int J Alzheimers Dis 2011, 603052.
31. Hicks DA, Nalivaeva NN, Turner AJ (2012) Lipid rafts and Alzheimer's disease: Protein-lipid interactions and perturbation of signaling. Front Physiol 3, 189.
32. Kenworthy AK, Petranova N, Edidin M (2000) High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11, 1645-1655.
33. Williams TL, Serpell LC (2011) Membrane and surface interactions of Alzheimer's Afj peptide-insights into the mechanism of cytotoxicity. FEBS J 278, 3905-3917.
34. Demuro A, Smith M, Parker I (2011) Single-channel Ca (2+) imaging implicates Afj1-42 amyloid pores in Alzheimer's disease pathology. J Cell Biol 195, 515-524.
35. Bettens K, Sleegers K, Van Broeckhoven C (2010) Current status on Alzheimer disease molecular genetics: From past, to present, to future. Hum Mol Genet 15, R4-R11.
36. Malchiodi-Albedi F, Paradisi S, Matteucci A, Frank C, Dio-ciaiuti M (2011) Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int J Alzheimers Dis 2011, 906-964.
37. Rushworth JV, Griffiths HH, Watt NT, Hooper NM (2013) Prion protein-mediated toxicity of amyloid-fj oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 288, 8935-8951.
38. Yanagisawa M, Ariga T, Yu RK (2006) Cholera toxin B sub-unit binding does not correlate with GM1 expression: A study using mouse embryonic neural precursor cells. Glycobiology 16, 19G-22G.
39. Cecchi C, Stefani M (2013) The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophys Chem 182, 30-43.
40. Sponne I, Fifre A, Koziel V, Oster T, Olivier JL, Pillot T (2004) Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide. FASEB J18, 836-838.
41. Kaether C, Haass C (2004) A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J Cell Biol 167, 809-812.
42. Levy M, Garmy N, Gazit E, Fantini J (2006) The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain. FEBS J 273, 5724-5735.
43. Capetillo-Zarate E, Staufenbiel M, Abramowski D, Haass C, Escher A, Stadelmann C, Yamaguchi H, Wiestler OD, Thal DR (2006) Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neu-rodegeneration in APP23 mice correlates with dendritic tree morphology. Brain 129, 2992-3005.
44. Fabelo N, Mart́in V, Maŕin R, Santpere G, Aso E, Ferrer I, D́iaz M (2012) Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease. J Neuropathol Exp Neurol 71, 868-881.
45. Kolsch H, Heun R, Jessen F, Popp J, Hentschel F, Maier W, Lütjohann D (2010) Alterations of cholesterol precursor levels in Alzheimer's disease. Biochim Biophys Acta 1801, 945-950.
46. Leduc V, Jasmin-Belanger S, Poirier J (2010) APOE and cholesterol homeostasis in Alzheimer's disease. Trends Mol Med 16, 469-477.
47. Fujita A, Cheng J, Hirakawa M, Furukawa K, Kusunoki S, Fujimoto T (2007) Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling. Mol Biol Cell 18, 2112-2122.
48. Molander-Melin M, Blennow K, Bogdanovic N, Dellheden B, Mansson JE, Fredman P (2005) Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J Neurochem 92, 171-182.
49. Williamson R, Usardi A, Hanger DP, Anderton BH (2008) Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J 22, 1552-1559.